PTN

Palatin Technologies, Inc.

$0.97 +$0.01 +0.52%


Own 4 of PTN at $0.87

+$0.11 (+12.39%)

Shares Bought5
Shares Sold1
Total6
Shares Owned4
Last Price$0.97
Total Return$0.42
Range Today$0.92 - $1.04
52 Week Range$0.29 - $1.05
Open$1.01
Market Cap$182.55M
Volume/Average3.03M/2.06M
P/E Ratio24.00
Dividend/Yield-




Palatin Technologies, Inc. is a biopharmaceutical company which develops targeted, receptor-specific peptide therapeutics for the treatment of diseases. It specializes in molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. It offers product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder, which is a type of female sexual dysfunction, defined as low desire with associated distress. It also offers drug candidates and development programs for cardiovascular diseases and inflammatory diseases. The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
11-10-17 18:57 $0.80 $0.97 +$0.18 +21.95% maxw6300
11-20-17 19:18 $0.89 $0.97 +$0.08 +9.55% sch3ct3r
11-20-17 19:19 $0.89 $0.97 +$0.08 +9.55% sch3ct3r
11-20-17 19:20 $0.89 $0.97 +$0.08 +9.55% sch3ct3r

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-10-17 18:56 11-15-17 17:54 $0.80 $0.79 -$0.01 -1.31% maxw6300